Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure. Dietz J, Mullhaupt B, Buggisch P, Graf C, et al. J Hepatol 2022 Aug 25. pii: S0168-8278(22)03016.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dietz J, Mullhaupt B, Buggisch P, Graf C, et al. Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure. J Hepatol 2022 Aug 25. pii: S0168-8278(22)03016.
PMID: 36031158